Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated with Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts

Circulation Research

Volumn 122, Issue 11, 2018, Pages 1555-1564

  Menni, Cristina ^a   Gudelj, Ivan ^c   MacDonald Dunlop, Erin ^d   Mangino, Massimo ^a,f   Zierer, Jonas ^a,g   Bešić, Erim ^h   Joshi, Peter K ^d   Trbojević Akmačić, Irena ^c   Chowienczyk, Phil J ^b   Spector, Tim D ^a   Wilson, James F ^d,e   Lauc, Gordan ^c,h   Valdes, Ana M ^a,i,j  

^a Department of Twin Research and Genetic Epidemiology ^*  (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^d Usher Institute of Population Health Sciences and Informatics   (Croatia)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h UNIVERSITY OF ZAGREB   (Croatia)

ⁱ NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^j NIHR NOTTINGHAM BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

more..

Author keywords

atherosclerosis; cardiovascular disease risk; glycosylation; immunoglobulin G; plaque, atherosclerotic

Indexed keywords

GLYCAN; GLYCOPROTEIN; IMMUNOGLOBULIN G; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; POLYSACCHARIDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; COHORT ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FEMORAL ARTERY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN GLYCOSYLATION; RISK ASSESSMENT; RISK FACTOR; UNITED KINGDOM; CAROTID ARTERY DISEASE; COMPLICATION; CONFIDENCE INTERVAL; DIAGNOSTIC IMAGING; GLYCOSYLATION; MALE; METABOLISM; MIDDLE AGED; ODDS RATIO; TWINS;

ADULT; AGED; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASES IN TWINS; FEMALE; FEMORAL ARTERY; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; POLYSACCHARIDES; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY;

EID: 85053274824     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.312174     Document Type: Article

References (45)

1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet 2015 385 117 171. doi: 10.1016/S0140-6736(14)61682-2.
2. Smolina K, Wright FL, Rayner M, Goldacre MJ, Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012 344 d8059
3. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A, Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005 365 434 441. doi: 10.1016/S0140-6736(05)17833-7.
4. Ridker PM, Buring JE, Rifai N, Cook NR, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007 297 611 619. doi: 10.1001/jama.297.6.611.
5. Assmann G, Cullen P, Schulte H, Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002 105 310 315
6. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S, Sega R, Pilotto L, Palmieri L, Giampaoli S, CUORE Project Research Group Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 2005 34 413 421. doi: 10.1093/ije/dyh405.
7. Goff DC Jr, Lloyd-Jones DM, Bennett G, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 S49 S73. doi: 10.1161/01.cir.0000437741.48606.98.
8. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB, General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008 117 743 753. doi: 10.1161/CIRCULATIONAHA.107.699579.
9. Laclaustra M, Casasnovas JA, Fernández-Ortiz A, Fuster V, León-Latre M, Jiménez-Borreguero LJ, Pocovi M, Hurtado-Roca Y, Ordovas JM, Jarauta E, Guallar E, Ibañez B, Civeira F, Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium: the AWHS Study. J Am Coll Cardiol 2016 67 1263 1274. doi: 10.1016/j.jacc.2015.12.056.
10. Polonsky TS, Ning H, Daviglus ML, Liu K, Burke GL, Cushman M, Eng J, Folsom AR, Lutsey PL, Nettleton JA, Post WS, Sacco RL, Szklo M, Lloyd-Jones DM, Association of cardiovascular health with subclinical disease and incident events: the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2017 6 e004894
11. Selwaness M, Bos D, van den Bouwhuijsen Q, Portegies ML, Ikram MA, Hofman A, Franco OH, van der Lugt A, Wentzel JJ, Vernooij MW, Carotid atherosclerotic plaque characteristics on magnetic resonance imaging relate with history of stroke and coronary heart disease. Stroke 2016 47 1542 1547. doi: 10.1161/STROKEAHA.116.012923.
12. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr, Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011 365 213 221. doi: 10.1056/NEJMoa1012592.
13. Inaba Y, Chen JA, Bergmann SR, Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012 220 128 133. doi: 10.1016/j.atherosclerosis.2011.06.044.
14. Ohtsubo K, Marth JD, Glycosylation in cellular mechanisms of health and disease. Cell 2006 126 855 867. doi: 10.1016/j.cell.2006.08.019.
15. Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, Raychaudhuri S, Ruhaak LR, Lebrilla CB, Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review. J Autoimmun 2015 57 1 13. doi: 10.1016/j.jaut.2014.12.002.
16. Chan AC, Carter PJ, Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 2010 10 301 316. doi: 10.1038/nri2761.
17. Akinkuolie AO, Buring JE, Ridker PM, Mora S, A novel protein glycan biomarker and future cardiovascular disease events. J Am Heart Assoc 2014 3 e001221. doi: 10.1161/JAHA.114.001221.
18. Lauc G, Pezer M, Rudan I, Campbell H, Mechanisms of disease: the human N-glycome. Biochim Biophys Acta 2016 1860 1574 1582. doi: 10.1016/j.bbagen.2015.10.016.
19. Willerson JT, Ridker PM, Inflammation as a cardiovascular risk factor. Circulation 2004 109 II2 I10. doi: 10.1161/01.CIR.0000129535.04194.38.
20. Lawler PR, Mora S, Glycosylation signatures of inflammation identify cardiovascular risk: some glyc it hot. Circ Res 2016 119 1154 1156. doi: 10.1161/CIRCRESAHA.116.310005.
21. Wang Y, Klarić L, Yu X, The association between glycosylation of immunoglobulin G and hypertension: a multiple ethnic cross-sectional Study. Medicine (Baltimore) 2016 95 e3379. doi: 10.1097/MD.0000000000003379.
22. Knezevic A, Gornik O, Polasek O, Pucic M, Redzic I, Novokmet M, Rudd PM, Wright AF, Campbell H, Rudan I, Lauc G, Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 2010 20 959 969. doi: 10.1093/glycob/cwq051.
23. Moayyeri A, Hammond CJ, Valdes AM, Spector TD, Cohort profile: Twinsuk and healthy ageing twin study. Int J Epidemiol 2013 42 76 85. doi: 10.1093/ije/dyr207.
24. McQuillan R, Leutenegger AL, Abdel-Rahman R, Runs of homozygosity in European populations. Am J Hum Genet 2008 83 359 372. doi: 10.1016/j.ajhg.2008.08.007.
25. Menni C, Migaud M, Glastonbury CA, Beaumont M, Nikolau A, Small K, Brosnan MJ, Mohney R, Spector TD, Valdes AM, Metabolomic profiling to dissect the role of visceral fat in cardiometabolic health. Obesity (Silver Spring) 2016 24 1380 1388. doi: 10.1002/oby.21488.
26. Cecelja M, Jiang B, Bevan L, Frost ML, Spector TD, Chowienczyk PJ, Arterial stiffening relates to arterial calcification but not to noncalcified atheroma in women. A twin study. J Am Coll Cardiol 2011 57 1480 1486. doi: 10.1016/j.jacc.2010.09.079.
27. Pucić M, Knezević A, Vidic J, High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 2011 10 M111.010090. doi: 10.1074/mcp.M111.010090.
28. Menni C, Keser T, Mangino M, Bell JT, Erte I, Akmačić I, Vučković F, Pučić Baković M, Gornik O, McCarthy MI, Zoldoš V, Spector TD, Lauc G, Valdes AM, Glycosylation of immunoglobulin G: role of genetic and epigenetic influences. PLoS One 2013 8 e82558. doi: 10.1371/journal.pone.0082558.
29. Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M, Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet 2015 8 192 206. doi: 10.1161/CIRCGENETICS.114.000216.
30. Aulchenko YS, Ripke S, Isaacs A, van Duijn CM, GenABEL: an R library for genome-wide association analysis. Bioinformatics 2007 23 1294 1296. doi: 10.1093/bioinformatics/btm108.
31. Würtz P, Havulinna AS, Soininen P, Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation 2015 131 774 785. doi: 10.1161/CIRCULATIONAHA.114.013116.
32. Joshi AA, Lerman JB, Aberra TM, GlycA is a novel biomarker of inflammation and subclinical cardiovascular disease in psoriasis. Circ Res 2016 119 1242 1253. doi: 10.1161/CIRCRESAHA.116.309637.
33. Lawler PR, Akinkuolie AO, Chandler PD, Moorthy MV, Vandenburgh MJ, Schaumberg DA, Lee IM, Glynn RJ, Ridker PM, Buring JE, Mora S, Circulating N-linked glycoprotein acetyls and longitudinal mortality risk. Circ Res 2016 118 1106 1115. doi: 10.1161/CIRCRESAHA.115.308078.
34. Niyonzima N, Halvorsen B, Sporsheim B, Garred P, Aukrust P, Mollnes TE, Espevik T, Complement activation by cholesterol crystals triggers a subsequent cytokine response. Mol Immunol 2017 84 43 50. doi: 10.1016/j.molimm.2016.09.019.
35. Otvos JD, Shalaurova I, Wolak-Dinsmore J, Connelly MA, Mackey RH, Stein JH, Tracy RP, GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem 2015 61 714 723. doi: 10.1373/clinchem.2014.232918.
36. Antman EM, Loscalzo J, Precision medicine in cardiology. Nat Rev Cardiol 2016 13 591 602. doi: 10.1038/nrcardio.2016.101.
37. Ruhaak LR, Uh HW, Beekman M, Koeleman CA, Hokke CH, Westendorp RG, Wuhrer M, Houwing-Duistermaat JJ, Slagboom PE, Deelder AM, Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity. PLoS One 2010 5 e12566. doi: 10.1371/journal.pone.0012566.
38. Itoh N, Sakaue S, Nakagawa H, Kurogochi M, Ohira H, Deguchi K, Nishimura S, Nishimura M, Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes. Am J Physiol Endocrinol Metab 2007 293 E1069 E1077. doi: 10.1152/ajpendo.00182.2007.
39. Clerc F, Reiding KR, Jansen BC, Kammeijer GS, Bondt A, Wuhrer M, Human plasma protein N-glycosylation. Glycoconj J 2016 33 309 343. doi: 10.1007/s10719-015-9626-2.
40. Umaña P, Jean-Mairet J, Moudry R, Amstutz H, Bailey JE, Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 1999 17 176 180. doi: 10.1038/6179.
41. Wahl A, Kasela S, Carnero-Montoro E, IgG glycosylation and DNA methylation are interconnected with smoking. Biochim Biophys Acta 2018 1862 637 648. doi: 10.1016/j.bbagen.2017.10.012.
42. Böhm S, Schwab I, Lux A, Nimmerjahn F, The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol 2012 34 443 453. doi: 10.1007/s00281-012-0308-x.
43. Tenenbaum A, Klempfner R, Fisman EZ, Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovasc Diabetol 2014 13 159. doi: 10.1186/s12933-014-0159-y.
44. Wolfe LA, Morava E, He M, Vockley J, Gibson KM, Heritable disorders in the metabolism of the dolichols: a bridge from sterol biosynthesis to molecular glycosylation. Am J Med Genet C Semin Med Genet 2012 160C 322 328. doi: 10.1002/ajmg.c.31345.
45. Sarphie TG, Interactions of IgG and beta-VLDL with aortic valve endothelium from hypercholesterolemic rabbits. Atherosclerosis 1987 68 199 212